Skip to main content
. 2025 Aug 12;16:1629473. doi: 10.3389/fimmu.2025.1629473

Figure 1.

Box plots display ELISA IgG levels across different groups and dosages at one and six months. Groups include healthy control, multiple myeloma, non-MM hematological, and solid malignancies. Geometric means, confidence intervals, and p-values are indicated for each group.

Anti-SARS-CoV-2 spike IgG levels post vaccination in serum samples from cancer and healthy cohorts. Comparison of serum anti-spike IgG levels in healthy, multiple myeloma, non-MM hematological cancer and solid cancer cohorts 1-month (A) and 6-months (B) post-vaccination. Anti-spike IgG levels were presented as Geometric Mean (GM) with 95% confidence intervals (95% CI). Box plots show median (horizontal bar), the first and third quartiles. Differences assessed by non-parametric Wilcoxon rank sum test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.